Need Help?

Transcriptomic profiling of RIRCD patient skeletal muscle, comparing recovered to affected disease phase.

Illumina MiSeq total RNA sequencing profiles of skeletal muscle biopsies from patient F3/1M during affected disease phase (4 replicates: F3-1M_Affected_1, F3-1M_Affected_2, F3-1M_Affected_3, F3-1M_Affected_4) compared to recovered phase (F3-1M_Recovered_1, F3-1M_Recovered_2, F3-1M_Recovered_3, F3-1M_Recovered_4).

Request Access

Data Access Policy of the research group of Rita Horvath, for use of data not associated with any other party or subject to other restriction.

In signing this agreement, You are agreeing to be bound by the terms and conditions of access set out in this agreement. For the sake of clarity, the terms of access set out in this agreement apply both to the User and the User’s Institution (as defined below). User Institution and User are referred to within the agreement as “You” and “Your” shall be construed accordingly. Data means all and any human genetic data contained with the study. User means a researcher whose User Institution has previously completed this Data Access Agreement and has received acknowledgement of its acceptance. Publications means, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. User Institution means the organisation at which the User is employed, affiliated or enrolled. 1. You agree to use the Data only for the advancement of medical research, according to the consent obtained from sample donors. 2. You agree to preserve confidentiality of information and Data pertaining to Data Subjects. You will not use Data to compromise the confidently of data subjects, on in any way affect their right to privacy. 2. You agree not to attempt to link the data provided under this agreement to other information or archive data available for the data sets provided, even if access to that data has been formally granted to you, or it is freely available without restriction, without specific permission being sought from the relevant access committees. 3. You agree not to transfer or disclose the Data, in whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or programme management. Should You wish to share the Data with a collaborator of a separate Institution, the third party must make a separate application for access to the Data. 4. You agree to use the data for the approved purpose and project described in your application; use of the data for a new purpose or project will require a new application and approval. 5. You agree to acknowledge in any work based in whole or part on the Data, the published paper from which the Data derives. 6. You accept that the original data creators, depositors or copyright holders, or the funders of the Data or any part of the Data supplied: a) bear no legal responsibility for the accuracy or comprehensiveness of the Data; and b) accept no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data, or from the unavailability of, or break in access to, the Data for whatever reason. 7. You accept that this agreement will terminate immediately upon any breach of this agreement by You, and You will be required to destroy any Data held. 8. You accept that the Data is protected by and subject to international laws, including but not limited to the UK Data Protection Act 1998, and that You are responsible for ensuring compliance with any such applicable law. The Data Access Committee reserves the right to refuse data access to Users in countries that have no national laws comparable to that which pertain in the EAA. 9. This agreement shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the non-exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004647 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00004671619 fastq.gz 998.4 MB
EGAF00004671620 fastq.gz 1.1 GB
EGAF00004671621 fastq.gz 991.7 MB
EGAF00004671622 fastq.gz 1.0 GB
EGAF00004671623 fastq.gz 1.0 GB
EGAF00004671624 fastq.gz 1.1 GB
EGAF00004671625 fastq.gz 998.1 MB
EGAF00004671626 fastq.gz 1.0 GB
EGAF00004671627 fastq.gz 984.9 MB
EGAF00004671628 fastq.gz 1.0 GB
EGAF00004671629 fastq.gz 979.7 MB
EGAF00004671630 fastq.gz 1.0 GB
EGAF00004671631 fastq.gz 993.1 MB
EGAF00004671632 fastq.gz 1.0 GB
EGAF00004671633 fastq.gz 988.5 MB
EGAF00004671634 fastq.gz 1.0 GB
16 Files (16.3 GB)